Market Research Life Sciences Market Research Pharmaceuticals Market Research Research & Development Market Research

Animal Testing And Non-Animal Alternative Testing Global Market Opportunities And Strategies To 2035

Best Price Guarantee Length Publisher Published Date SKU
from $5,000 240 Pages The Business Research Company May, 2023 BRC17954961
Best Price Guarantee
Price from $5,000
Length 240 Pages
Publisher The Business Research Company
Published Date May, 2023
SKU BRC17954961

Animal Testing And Non-Animal Alternative Testing Global Market Opportunities And Strategies To 2035

Including: 1) By End-User: Pharmaceuticals; Academic Research; Medical Devices; Chemicals & Pesticides; CosmeticsCovering: Cyprotex; Bio-Rad Laboratories, Inc; BioIVT; Emulate, Inc; MatTek Corporation


Animal Testing And Non-Animal Alternative Testing Global Market Opportunities And Strategies To 2035 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global animal testing and non-animal alternative testing market as it emerges from the COVID-19 shut down.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Description:

Where is the largest and fastest growing market for animal testing and non-animal alternative testing? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The animal testing and non-animal alternative testing market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider animal testing and non-animal alternative testing market; and compares it with other markets.

The report covers the following chapters:
  • Introduction and Market Characteristics
Brief introduction to the segmentations covered in the market, definitions and explanations about the animal testing and non-animal alternative testing market.
  • Market Value Chain Analysis
This section gives information on value chain analysis for the animal testing and non-animal alternative testing markets.
  • Non-Animal Alternative Testing Trends
This chapter describes the major trends shaping the global non-animal alternative testing market.
  • Cost Analysis For Animal Testing and Alternative Technologies
This section describes the comparative cost analysis for animal testing and alternative methods to understand the cost-effectiveness and time efficiency of alternative methods. It includes the average cost of animal species and the cost of alternatives to conventional animal testing methods.
  • Animal Testing And Non-Animal Alternative Testing By Type And End Use
This section describes the overview of the types of non-animal alternative testing technologies. It also highlights the major developers and end-use industries in non-animal alternative testing technologies in the major geographies.
  • End-User Industries Adoption To Alternative Technologies
This section details information on the adoption of alternative technologies by top end-use industries in the USA, Germany, France, UK, and Japan. This section also includes the adoption of 3R principles by each of the top industries in the USA, China, and Europe.
  • Global Market Size
This section provides information on the global animal testing and non-animal alternative testing market by value and volume for the current and forecast period (2019-2035) and the drivers and restraints that support the growth of the market during this period.
  • Regional And Country Analysis
This section contains the animal testing market by value and volume, and non-animal alternative testing market by value for the major geographies for the current and forecast period (2019-2035). This section also provides end-use industries segmentation in animal alternative testing in the major geographies.
  • Animal Testing Regulatory Landscape
This section describes the regulatory landscape for animal testing and its alternatives in major geographies. It includes information on regulatory agencies and policies governing animal testing. This section also includes the proposed regulations and guidelines that are driving the non-animal alternative testing technologies market in major geographies.
  • Competitive Landscape For Alternative Technologies
This section briefs information on major companies involved in the alternative technology market in the USA, China, and Europe. This section includes the profiles of the major alternative technology developers with information on their product portfolio, financial analysis, and strategies implemented by these companies.
  • Market Opportunities And Strategies
This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • Conclusions And Recommendations
This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for animal testing and non-animal alternative testing providers in terms of product/service offerings, geographic expansion, marketing strategies and target groups.
  • Appendix
This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope:

Markets Covered: 1) By End-User: Pharmaceuticals; Academic Research; Medical Devices; Chemicals & Pesticides; Cosmetics; Other End Users


Companies Mentioned: Cyprotex; Bio-Rad Laboratories, Inc; BioIVT; Emulate, Inc; MatTek Corporation
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; animal testing and non-animal alternative testing indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.


1. Executive Summary
2. Table of Contents
3. List of Figures
4. List of Tables
5. Report Structure
6. Introduction and Market Characteristics
6.1. General Market Definition
6.2. Animal Testing And Non-Animal Alternative Testing Market Definition And Segmentations
6.2.1. Animal Testing
6.2.2. Non-Animal Alternative Testing
6.2.3. Facts About Animals In Research - Functional Resemblances Of Animals To Human Body
6.3. Market Segmentation By End-Use Industry
6.3.1. Pharmaceuticals
6.3.2. Academic Research
6.3.3. Medical Devices
6.3.4. Chemicals And Pesticides
6.3.5. Cosmetics
6.3.6. Other End Users
7. Value Chain Analysis
7.1.1. Animal Breeders and Suppliers
7.1.2. Non-Animal Alternative Testing Technology Developers
7.1.3. Regulatory Authorities
7.1.4. Alternative Testing Service Providers
7.1.5. End-Use Industries
7.1.6. Clinical Trials
8. Non-Animal Alternative Testing Trends
8.1. Developments In OOC (organ-on-chip) For Testing
8.2. Adoption Of In Silico Trials
8.3. Use Of Model Organisms
8.4. Focus On 3D-Printed Organs For Testing
8.5. Increasing Collaborations And Partnerships To Reduce Animal Testing
8.6. Rising Initiatives And Grants To Promote Animal-Free Testing
9. Cost Analysis For Animal Testing And Alternative Technologies
9.1.1. Average Cost Of Laboratory Animals
9.1.2. Average Cost Of Non-Animal Alternative Testing Methods
9.1.3. Comparative Cost Analysis For Animal Testing And Alternative Methods
9.2. Costs Involved In Animal Testing, 2021
10. Animal Testing And Non-Animal Alternative Testing Market Segments
10.1. By End Use Industrial Application
10.1.1. Important Areas of Use
10.1.2. Basic Research
10.1.3. Applied Research
10.1.4. Regulatory Testing
10.1.5. Development Of New Diagnostic Methods
10.1.6. Breeding Of Genetically Altered Animals
10.1.7. Animal Cloning
10.2. End-User Applications
10.3. Animal Testing Market By Animal Type
10.3.1. Mice
10.3.2. Rat
10.3.3. Frogs
10.3.4. Fish
10.3.5. Birds
10.3.6. Guinea pig
10.3.7. Hamster
10.3.8. Rabbits
10.3.9. Sheep
10.3.10. Dogs
10.3.11. Cats
10.3.12. Monkeys
10.3.13. Pigs
10.3.14. Others
11. Number Of Animals Used In Research, By Country
11.1.1. USA
11.1.2. Europe
11.1.3. United Kingdom (UK)
11.1.4. Germany
11.1.5. France
11.1.6. Australia
11.1.7. Canada
11.1.8. China
12. Non-Animal Alternative Testing Technologies By Type And End Use
12.1. Introduction
12.2. Types Of Non-Animal Alternative Testing Technologies
12.2.1. Cell Or Tissue Culture (In-Vitro)
12.2.2. Major Cell Culture Developers Worldwide
12.2.3. Organ-On-Chip (OOC)
12.2.4. Global OOC Market Size And Growth
12.2.5. OOC Market Drivers And Restraints
12.2.6. Market Drivers
12.2.7. Market Restraints
12.2.8. In-silico (Computer-Based Models)
12.2.9. Artificial Skin Models (Skin Substitutes)
12.2.10. Other Technologies
13. End-User Industries Adoption Of Alternative Testing Technologies
13.1. Adoption of Alternative Testing Technologies By Type of Industry
13.1.1. Cosmetics Industry
13.1.2. Pharmaceutical Industry
13.1.3. Medical Device Industry
13.1.4. Others
13.2. Adoption of 3R’s In USA
13.2.1. 3R Adoption In The Cosmetics Industry
13.2.2. 3R Adoption In The Pharmaceutical Industry
13.2.3. 3R Adoption In The Medical Device Industry
13.3. Adoption of 3R’s In China
13.3.1. 3R Adoption In The Cosmetics Industry
13.3.2. 3R Adoption In The Pharmaceutical Industry
13.3.3. 3R Adoption In The Medical Device Industry
13.4. Adoption of 3R’s In Europe
13.4.1. 3R Adoption In The Cosmetics Industry
13.4.2. 3R Adoption In The Pharmaceutical Industry
13.4.3. 3R Adoption In The Medical Device Industry
14. Global Animal Testing And Non-Animal Testing Market
14.1. Global Animal Testing Market Size And Growth
14.1.1. Global Animal Testing Market Value ($ Billion)
14.1.2. Global Animal Testing Market, By Volume (Million Units)
14.1.3. Animal Testing Market Drivers
14.1.4. Animal Testing Market Restraints
14.2. Global Non-Animal Alternative Testing Market Size And Growth
14.2.1. Global Non-Animal Alternative Testing Market Value ($ Billion)
14.2.2. Non-Animal Alternative Testing Market Drivers
14.2.3. Non-Animal Alternative Testing Market Restraints
15. Animal Testing And Non-Animal Testing Market, Regional And Country Analysis
16. USA Animal Testing And Non-Animal Alternative Testing Market
16.1. USA Animal Testing Market
16.1.1. USA Animal Testing Market Value ($ Billion)
16.1.2. USA Animal Testing Market, By Volume (Million Units)
16.2. USA Non-Animal Alternative Testing Market
16.2.1. USA Non-Animal Alternative Testing Market Value ($ Billion)
16.3. USA Animal Testing Market By End Use Industrial Application
16.3.1. Market By Value And Volume
16.3.2. Share Of Top 5 Companies, By Revenue (In Each Industrial Application)
16.4. Regulatory Landscape In The USA
16.4.1. Regulatory Bodies & Policies
16.4.2. Proposed Regulations & Guidelines Driving The Animal Testing Alternatives Market
16.4.3. USDA & Animal Welfare Act
16.4.4. ICCVAM
16.4.5. FDA
16.4.6. NIH
17. Japan Animal Testing And Non-Animal Alternative Testing Market
17.1. Japan Animal Testing Market
17.1.1. Japan Animal Testing Market Value ($ Billion)
17.1.2. Japan Animal Testing Market, By Volume (Million Units)
17.2. Japan Non-Animal Alternative Testing Market
17.2.1. Japan Non-Animal Alternative Testing Market Value ($ Billion)
17.3. Japan Animal Testing Market By End Use Industrial Application
17.3.1. Share Of Top 5 Companies, By Revenue (In Each Industrial Application)
17.4. Regulatory Landscape In Japan
17.4.1. Regulatory Bodies & Policies
17.4.2. Proposed Regulations & Guidelines Driving Animal Testing Alternatives Market
17.4.3. Law for the Humane Treatment and Management of Animals
17.4.4. MHLW, MEXT, And MAFF
18. China Animal Testing And Non-Animal Alternative Testing Market
18.1. China Animal Testing Market
18.1.1. China Animal Testing Market Value ($ Billion)
18.1.2. China Animal Testing Market, By Volume (Million Units)
18.2. Regulatory Landscape In China
18.2.1. Regulatory Bodies & Policies
18.2.2. Proposed Regulations & Guidelines Driving Animal Testing Alternatives Market
19. Australia Animal Testing And Non-Animal Alternative Testing Market
19.1. Australia Animal Testing Market
19.1.1. Australia Animal Testing Market Value ($ Billion)
19.1.2. Australia Animal Testing Market, By Volume (Million Units)
19.2. Regulatory Landscape In Australia
19.2.1. Regulatory Bodies & Policies
19.2.2. Proposed Regulations & Guidelines Driving The Animal Testing Alternatives Market
20. Europe Animal Testing And Non-Animal Alternative Testing Market
20.1. Regulatory Landscape In Europe
20.1.1. EU Directive 2010/63
20.2. Europe Non-Animal Alternative Testing Market
20.2.1. Europe Non-Animal Alternative Testing Market Value ($ Billion)
21. France Animal Testing And Non-Animal Alternative Testing Market
21.1. France Animal Testing Market
21.1.1. France Animal Testing Market Value ($ Billion)
21.1.2. France Animal Testing Market, By Volume (Million Units)
21.2. France Animal Testing Market By End Use Industrial Application
21.2.1. Market By Value
21.3. Regulatory Landscape In France
21.3.1. Regulatory Bodies & Policies
21.3.2. Proposed Regulations & Guidelines Driving The Animal Testing Alternatives Market
22. Germany Animal Testing And Non-Animal Alternative Testing Market
22.1. Germany Animal Testing Market
22.1.1. Germany Animal Testing Market Value ($ Billion)
22.1.2. Germany Animal Testing Market, By Volume (Million Units)
22.2. Germany Animal Testing Market By End Use Industrial Application
22.2.1. Market By Value
22.3. Regulatory Landscape In Germany
22.3.1. Regulatory Bodies & Policies
22.3.2. Proposed Regulations & Guidelines Driving the Animal Testing Alternatives Market
23. UK Animal Testing And Non-Animal Alternative Testing Market
23.1. UK Animal Testing Market
23.1.1. UK Animal Testing Market Value ($ Billion)
23.1.2. UK Animal Testing Market, By Volume (Million Units)
23.2. UK Animal Testing Market By End Use Industrial Application
23.2.1. Market By Value
23.3. Regulatory Landscape in United Kingdom (UK)
23.3.1. Regulatory Bodies & Policies
23.3.2. Proposed Regulations & Guidelines Driving the Animal Testing Alternatives Market
24. Canada Animal Testing And Non-Animal Alternative Testing Market
24.1. Canada Animal Testing Market
24.1.1. Canada Animal Testing Market Value ($ Billion)
24.1.2. Canada Animal Testing Market, By Volume (Million Units)
24.2. Regulatory Landscape In Canada
24.2.1. Regulatory Bodies & Policies
24.2.2. Proposed Regulations & Guidelines Driving Animal Testing Alternatives Market
25. Rest Of The World Animal Testing And Non-Animal Alternative Testing Market
25.1. Rest Of The World Animal Testing Market
25.1.1. Rest Of The World Animal Testing Market Value ($ Billion)
25.1.2. Rest Of The World Animal Testing Market, By Volume (Million Units)
25.2. Rest of The World Non-Animal Alternative Testing Market
25.2.1. Rest of The World Non-Animal Alternative Testing Market Value ($ Billion)
25.3. Regulatory Landscape In Rest of the World (RoW)
25.3.1. Regulatory Bodies & Policies
25.3.2. Proposed Regulations & Guidelines Driving Animal Testing Alternatives Market
26. Non-Animal Alternatives Testing Competitive Landscape And Company Profiles
26.1. Company Profiles
26.2. Cyprotex
26.2.1. Company Overview
26.2.2. Products And Services
26.2.3. Business Strategy
26.2.4. Financial Overview
26.3. Bio-Rad Laboratories, Inc.
26.3.1. Company Overview
26.3.2. Products And Services
26.3.3. Business Strategy
26.3.4. Financial Overview
26.4. BioIVT
26.4.1. Company Overview
26.4.2. Products And Services
26.4.3. Business Strategy
26.4.4. Financial Overview
26.5. Emulate, Inc
26.5.1. Company Overview
26.5.2. Products And Services
26.5.3. Business Strategy
26.5.4. Financial Overview
26.6. MatTek Corporation
26.6.1. Company Overview
26.6.2. Products And Services
26.6.3. Business Strategy
26.6.4. Financial Overview
26.7. USA Non-Animal Alternative Testing Market Competitive Landscape
26.7.1. Organovo Holdings, Inc
26.7.2. MatTek Corporation
26.7.3. EMD Millipore
26.8. Japan Non-Animal Alternative Testing Market Competitive Landscape
26.8.1. Japan Tissue Engineering Co., Ltd. (J-TEC)
26.8.2. ReproCell Inc
26.8.3. Organ Technologies Co, Ltd
26.9. Europe Non-Animal Alternative Testing Market Competitive Landscape
26.9.1. Episkin
27. Animal Testing And Non Animal Alternative Testing Global Market Opportunities And Strategies
27.1. Global Animal Testing Market In 2035 – Geographies Offering Most New Opportunities
27.2. Global Non-Animal Alternative Testing Market In 2035 – Geographies Offering Most New Opportunities
27.3. Global Animal Testing And Non-Animal Alternative Testing Market In 2035 – Segments Offering Most New Opportunities
27.4. Global Animal Testing And Non-Animal Alternative Testing Market In 2025 – Growth Strategies
27.4.1. Non-Animal Alternative Testing Market Trend Based Strategies
27.4.2. Competitor Strategies
28. Conclusions & Recommendations
28.1. Conclusions
28.2. Recommendations
28.2.1. Product
28.2.2. Price
28.2.3. Place
28.2.4. Promotion
28.2.5. People
29. Appendix
29.1. Glossary
29.2. Market Data Sources
29.3. Research Methodology
29.3.1. OCED Accepted In Vito Tests

$5,000
$7,500
$10,000

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings